Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Privi Medical is a Singapore medical device company focused on non-drug treatment of hemorrhoidal symptoms, particularly early-stage internal hemorrhoids. The company was spun out of the Stanford Byers Center for Biodesign and the Singapore-Stanford Biodesign programs and developed Instalief, a disposable, drug-free device that uses instant cold compression technology. Privi announced U.S. FDA clearance for Instalief in January 2018 for adult use, positioning the product as a home-use alternative to topical drug-based hemorrhoid treatments. The company appears to have remained an active legal entity in Singapore after being acquired by HeMo in October 2021. Overall, Privi Medical is a single-product medtech company rather than a therapeutics biotech or platform company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Privi Medical.